Background Indigenous populations in the United States experience disproportionate substance use and opioid overdose burdens. Yet, little is known about naloxone distribution in Indigenous communities on Tribal reservation lands.
Schneider et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: